Kevin Leyden has been a registered nurse for nearly 15 years, with experience in
medical/surgical, emergency, and addictions nursing. He currently specializes in infectious
diseases, particularly hepatitis C. Since joining North Jersey Community Research
Initiative (NJCRI), Kevin has led the creation, development, and management of the
statewide HCV Elimination Program, which serves all 21 counties in New Jersey and has
coordinated care for over 2,200 patients. Through his efforts, he has built a network of

Dr. Lindsey Sheehan is the Associate Director of Specialty Pharmacy Collaborations at University of Kentucky HealthCare. Upon graduation from the University of Kentucky College of Pharmacy, Dr. Sheehan completed a PGY1 pharmacy residency at UK HealthCare and a PGY2 in Specialty Pharmacy Administration and Leadership at UK Specialty Pharmacy and Infusion Services (UKSPIS).

Scott R. Springer is a certified physician assistant at ECMC's Center for Hepatology Care, also known as "La Bodega". He cares for patients with liver disease and substance use disorders. Scott has presented on the treatment of MASLD/MASH, viral hepatitis, and alcohol-associated liver disease at the local, state, and national levels, and precepts medical providers and students from throughout New York State. Scott is a founding member of ECMC's Harm Reduction Coalition and has been named an 2024 Emerging Liver APP by the American Association for the Study of Liver Disease.

Nicola Pugliese is a board-certified gastroenterologist who is currently working as an Attending Physician in the Hepatology and Endoscopy Units at Humanitas Research Hospital and as an Adjunct Teaching Professor at Humanitas University in Milan, Italy. His clinical and research interests include viral hepatitis, MASLD and vascular liver disorders. In recent years, the focus of his research has increasingly shifted towards the clinical application of artificial intelligence to enhance patient care.

Richard Jaenisch, MPH is a patient advocate for liver transplantation, and HCV. As a survivor and caregiver, he extends his lived experience to his work at both Open Biopharma Research and Training Institute and Prompting Integration and Consulting LLC. Richard has always been involved in the digital patient experience from online moderation of forums, content creation and being a patient stakeholder, this is continued this by expanding his area of advocacy to include work in data and artificial intelligence.

Dr. Christina Lindenmeyer is an Assistant Professor of Medicine and Staff Transplant Hepatologist in the Department of Gastroenterology, Hepatology and Nutrition. After graduating from Jefferson Medical College in Philadelphia, Dr. Lindenmeyer completed her residency in Internal Medicine at Thomas Jefferson University Hospital. She then completed fellowships in Gastroenterology and Transplant Hepatology at the Cleveland Clinic in Cleveland, Ohio.​

Vice President of Data Strategy @GENFIT, leading strategic & operational projects in acute-on-chronic liver failure & liver-associated syndromes. Former pharma strategy consultant with a molecular biology background.

Jasmohan S. Bajaj, is Professor of Medicine in the Division of Gastroenterology, Hepatology and Nutrition at Virginia Commonwealth University and Richmond VA Medical Center in Richmond, Virginia. Dr. Bajaj finished training in India, followed by Medicine and GI/Hepatology training in the United States. He also earned a master's degree in Epidemiology. Active in research, Dr. Bajaj has served as a principal investigator or co‐investigator for numerous clinical trials in hepatic encephalopathy, chronic liver disease, and microbiome. Dr.